Pediatric sepsis diagnostic and prognostic biomarkers: pancreatic stone protein, copeptin, and apolipoprotein A-V

  • 类型:
  • 作者:Saleh Nagwan Y., Aboelghar Hesham M., Garib Mohamed I., Rizk Mohammed S., Mahmoud Asmaa A.
  • 期刊:PEDIATRIC RESEARCH
  • 阅读原文

Background We assessed serum concentrations of pancreatic stone protein (PSP), copeptin, and apolipoprotein A-V (APOA5) biomarkers for the diagnosis and prognosis of pediatric sepsis, a condition associated with high mortality. Methods This prospective study included 180 children admitted to the Pediatric Intensive Care Unit and 100 healthy controls at Menoufia University Hospital. Pediatric Risk of Mortality (PRISM), Pediatric Index of Mortality-2 (PIM2), and Pediatric Sequential Organ Failure Assessment (pSOFA) scores were calculated. Serum PSP, copeptin and APOA5 were measured once within 24?h of admission. Results PSP, copeptin, and APOA5 were significantly higher in the patients than in the controls ( p ?

Apolipoprotein A-V (APOA5), copeptin, and pancreatic stone protein (PSP) are acute-phase proteins with diagnostic value in evaluating critically ill pediatric patients with sepsis and detecting sepsis severity.

PSP and copeptin had the power to discriminate non-survivors from survivors.

APOA5 was less powerful than the other biomarkers in discriminating between survivors and non-survivors.

引用产品已停售或下架

待确认